This study looks at how well and safely **Suzetrigine**, a new medicine, works for people with pain from **diabetic peripheral neuropathy (DPN)**. DPN is a problem where diabetes causes nerve damage, often leading to pain in the feet and legs. If you join, you need to weigh at least 45 kilograms, have a body mass index (BMI) between 18 and 40, and have diabetes with pain in both legs. Your average daily pain score should be between 4 and 9 during the first week. You cannot join if you have been in another Suzetrigine study or have more than 3 missing pain scores in the first week.

• The study checks if Suzetrigine helps reduce pain safely.
• Participants must have diabetes with leg pain and meet weight and BMI requirements.
• You cannot join if you've been part of a Suzetrigine study before.